The Effectiveness of Early Treatment with “Second-Line” Antirheumatic Drugs
Early introduction of SAARDs may be more beneficial than delayed introduction for patients with recently diagnosed rheumatoid arthritis.
Publications
1 shownFrequent Co-Authors
Researcher Info
- h-index
- 1
- Publications
- 1
- Citations
- 473
- Institution
- Erasmus University Rotterdam
External Links
Identifiers
- ORCID
- 0000-0001-5584-4305
Impact Metrics
h-index
1
h-index: Number of publications with at least h citations each.